<DOC>
	<DOC>NCT00385944</DOC>
	<brief_summary>This is a multicenter, randomized, double-blind, cross-over study to compare the pharmacodynamic response in subjects with Acute Coronary Syndrome receiving a 10-mg maintenance dose (MD) of prasugrel compared with a 150-mg maintenance dose of clopidogrel, following a 900-mg loading dose (LD) of clopidogrel.</brief_summary>
	<brief_title>The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>Present with acute coronary syndrome (ACS) and have planned treatment with a onetime 900mg loading dose of commercially available clopidogrel (administered as a single or cumulative dose). Are between the ages of 18 and 85 years. Willing and able to sign informed consent. Have overt STsegment elevation myocardial infarction (STEMI). Have cardiogenic shock. Have refractory ventricular arrhythmias. Have New York Heart Association (NYHA) Class IV congestive heart failure. Have severe and uncontrolled hypertension. Have active internal bleeding or history of bleeding diathesis. Have an increased risk of bleeding. Have history of cerebrovascular accidents. Have certain abnormal blood level values. Are currently receiving chemotherapy or radiation therapy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>